Elucidation of Small Molecule Markers in Cancer Cells by NMR Spectroscopy, Greg Heffron, Harvard Med, 20-Oct-2011, Takeda
Characterization of Pharmaceuticals Using Solid-State NMR Spectroscopy, Eric Munson, U. Kentucky, 26-Jan-2012, MIT
New NMR experiments for challenging proteins, Gerhard Wagner, Harvard, 27-Jun-2012, Northeastern Univ.
Utilizing Metabolomics to understand biochemical mechanism - seeing and solving unknowns, Qiuwei Xu, Merck, 09-Oct-2012, Amgen
Chemical Counterterrorism: The Organization for the Prohibition for Chemical Weapons and the role NMR plays at LLNL, Brian Mayer, LLNL, 08-Nov-2012, MIT
NMR Crystallography Applications to Drug Development, Heather Fredicks Scmidt, Pfizer, 24-Jan-2013, Amgen
The Many and Wonderful uses of NMR in Process Development, Edward R. Zartler, Quantum Tessera Consulting, 30-April-2013, Takeda
NMR Screening in Fragment Based Ligand Discovery: From weak hits to highly potent inhibitors of Lactate Dehydrogenase A., Stephan G. Zech, ARIAD, 18-Sep-2013, Takeda
Applications of Quantitative NMR/MRI Employing Cap-Pack Devices, Rex Gerhald, Missouri U. of Science & Tech, 15-Oct-2013, MIT
Building Buoyancy: NMR Studies of the Floatation Organelles of Aquatic Microorganisms, Judith Herzfeld, Brandeis University, 26-Feb-2014, Amgen
My Pathway into Science and Beyond, Richard Ernst, ETH Zürich, 28-March-2014, Northeastern
Assessment of Druggability of Protein-Protein Interaction Drug Targets by Using a Combination of NMR, Small-Angle X-ray Scattering and Computational Fragment Mapping, Stefan Jehle, Boston University, 14-May-2014, Takeda
Developing A Fully Automated Fragment Based Drug Design Screen for NMR, Bill Marathias, Agilent, 28-Oct-2014, MIT
Small Molecule Structure Characterization: New and Improved NMR Methods, R. Thomas Williamson, Merck, 05-Dec-2014, Amgen
A case study of the "80/20" rule applied to single-substrate screening of enzymes by STD NMR, Yael Balazs, Technion, 15-April-2015, Takeda
Use of NMR data for decision making: tau aggregation inhibitor case study, Hai-Young Kim, Merck, 17-June-2015, Merck
NMR strategies for antibacterial drug discovery, Michael Mesleh, Broad Institute MIT, 18-Nov-2015, Takeda
InsightMR – A Hardware and Software Solution for Reaction Monitoring by NMR, Robert Krull, Bruker, 23-March-2016, Takeda
Development and Application of Novel NMR Methods to Solve Challenging Small Molecule Structure Elucidation Problems, Josep Sauri, Merck, 03-Aug-2016, Merck
MRI unchained; removing hardware constraints to make faster, portable and motion tolerant images, Larry J Wald, MIT/Harvard, 01-June-2017, Amgen
Already Producing or Still Calibrating? – Online NMR Spectroscopy as a Smart Field Device, Michael Maiwald, BAM, 02-March-2018, Takeda
Developing Chemical Reactions using NMR Spectroscopy, David Foley, Pfizer, 24-March-2018, Amgen
NMR of Pharmaceutical Metabolites: Structures and Quantitation of nmole Isolates, Gregory S Walker, Pfizer, 13-Feb-2019, Takeda
CMOS-based sensor for micro-NMR: magnetic resonance at the embryo scale, Marco Grisi, EPFL Institute of Microengineering, 12-March-2019, MIT
Exploring the periodic table, NMR Beyond Proton, Carbon and Nitrogen, Clemens Anklin, Bruker, 25-Sep-2019, Takeda
A new ‘spin’ from small molecule NMR: Incorporating free ligand 1D NMR conformational signatures into drug design, Amber Balazs, AstraZeneca, 29-Oct-2019, MIT
Therapeutic targeting of SREBP-dependent lipogenesis – fluorine NMR in drug discovery, Andras Boeszoermenyi, Dana-Farber Cancer Institute, 11-Dec-2019, Amgen
Discovering Drug Leads by Practical NMR Strategies, Steven LaPlante, Université du Quebec INRS, 13-Jan-2020, Takeda
Screening and Beyond: Opportunities for Protein NMR Spectroscopy in the Pharmaceutical Industry, Reto Horst, Pfizer, 12-August-2020, Zoom
NMR in Shared Labs in the COVID-19 Era, Walt Massefski, MIT, 16-Sep-2020, Zoom
Overcoming challenges in heteronuclear NMR imposed from wide bandwidths and large couplings with Perfluorinated Compounds, Ron Crouch & Gary Martin, Jeol, 14-Oct-2020, Zoom
Building a Successful Applied Industrial Research Organization: the story of Novatia LLC, David Detefsen, Novatia, 24-Feb-2021, Zoom
NMR and Mass Spectroscopy goes mobile: Using NMR and MS as Process Analytical Technologies at the fume hood, Mark J. Milton, Takeda, 28-March-2021, Zoom
Some observations related to diffusion experiments, Bruce Adams, MIT, 03-Nov-2021, Zoom
NMR conformations & dynamics of free ligands for drug design, Amber Balaz, Astra Zeneca, 08-Dec-2021, Zoom
From Big to Small … and Back Again: Quantitative Interpretation of Molecular Diffusion Coefficients Rob Evans Ph.D. Aston University, 07-SEP-2022
